KoideN., SakaguchiK., KoideY.. Formation of multicelluar spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments.Exp Cell Res1990; 186: 227–35.
2.
TongJ.G., LagausieP.D., FurlanV., CresteilT., BernardO., AlvarezF.Long-term culture of adult rat hepatocyte spheroids.Exp Cell Res1992; 200: 326–32.
3.
SakaiY., NaruseK., NagashimaI.Muto T, Suzuki M. Large-scale preparation and function of porcine hepatocyte spheroids.Int J Artif Organs1996; 19: 294–301.
4.
LazarA., MannH.J., RemmelR.P., ShatfordR.A., CerraF.B., HuW.S.Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel.In Vitro Cell Dev Biol1995; 31: 340–6.
5.
IjimaH., MatsushitaT., NakazawaK., FujiiY., FunatsuK.Hepatocyte spheroids in polyurethane foams: Functional analysis and application for a hybrid artificial liver.Tissue Eng1998; 4: 213–26.
6.
IjimaH., NakazawaK., MizumotoH., MatsushitaT., FunatsuK.Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver.J Biomater Sci Polymer Edn1998; 9: 765–78.
RozgaJ., WilliamsF., RoM.S.. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells.Hepatology1993; 17: 258–65.
9.
StevensA.C., BusuttilR., HanS.. An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the HepatAssist bioartificial liver support system for the treatment of fulminant hepatic failure.Hepatology2001; 34: 299A.
10.
UchinoJ., TsuburayaT., KumagaiF.. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.ASAIO Trans1988; 34: 972–7.
SchonfeldW., MaguireP., ScottE., LibbyK., BrodM.The cost effectiveness of an extra-corporeal liver assist device as a bridge to transplant for patients with fulminant hepatic failure.Hepatology2001; 34: 190A.
13.
GerlachJ.C., EnckeJ., HoleO.. Bioreactor for a larger scale hepatocyte in vitro perfusion.Transplantation1994; 58: 984–8.
14.
SauerI.M., KardassisD., ObermayerN.. Clinical course of patients with acute liver failure treated with an extracorporeal liver support system - a matched pair analysis.ASAIO J2001; 47: 170.
15.
PatzerJ.F.II, MazariegosG.V., KramerD.J.. Novel bioartificial liver support system: preclinical evaluation. In: HunkelerD., ProkopA., CherringtonA.D., RajotteR.V., SeftonM., eds. Bioartificial organs II.New York: The New York Academy of Sciences; 1999. p. 340–52.
16.
PatzerJ.F.II, KramerD.J., MazariegosG.V.. Novel bioartificial liver support system (BLSS): Clinical experience.ASAIO J2000; 46: 241.
FlendrigL.M., CaliseF., DiflorioE.. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver.Int J Artif Organs1999; 22: 701–8.
19.
NaruseK., SakaiY., NagashimaI., JiangG.X., SuzukiM., MutoT.Comparisons of porcine hepatocyte spheroids and single hepatocytes in the non-woven fabric bioartificial liver module.Int J Artif Organs1996; 19: 605–9.
20.
IjimaH., NakazawaK., KoyamaS.. Conditions required for a hybrid artificial liver support system using a PUF/ hepatocyte-spheroid packed-bed module and it's use in dogs with liver failure.Int J Artif Organs2000; 23: 446–53.
